Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biokine EC
- Development stage
- Unknown
- Lead developer
- Adamas Biotech
- Administration
- Topical
01
Overview
Biokine EC is a topical nutraceutical product developed by Adamas Biotech, currently in Phase 1 clinical development for erythema care. The product is designed to address skin redness and irritation, likely through the antioxidant and anti-inflammatory actions of green tea extracts. It is positioned as a specialized care solution for dermal erythema, aiming to mitigate skin inflammation and provide protective effects through its bioactive components.
- Brand names
- Biokine EC
- Other names
- Biokine Erythema CareBiokine EC (Erythema care)
Beyond the preview
Go deeper on Biokine EC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biokine EC.